@article{0cd824d664fb4b35a39fea26889a4470,
title = "Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients",
author = "JJ Zwaginga and \{van der Holt\}, Ronnie and \{te Boekhorst\}, Peter and BJ Biemond and MD Levin and \{van der Griend\}, R and A Brand and S Zweegman and HFM Pruijt and Novotny, \{Viera M.J.\} and A Vreugdenhil and \{De Groot\}, MR and \{de Weerdt\}, O and \{van Pampus\}, \{E C M\} and \{van Maanen-Lamme\}, \{T M\} and S Wittebol and Schipperus, \{MR (Martin)\} and MH Silbermann and PC Huijgens and Marleen Luten and Rene Hollestein and Brakenhoff, \{J A C\} and JG Schrama and FAA Valster and Velders, \{G A\} and Koene, \{H R\} and Dutch, \{Hovon Study Grp\}",
year = "2015",
doi = "10.3324/haematol.2014.110213",
language = "Undefined/Unknown",
volume = "100",
pages = "E90--E92",
journal = "Haematologica",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "3",
}